Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

Completed · Phase 2

Conditions studied: Pemphigus

In brief

OBJECTIVES: I. Determine the response rate and 1-year event-free survival of patients with refractory pemphigus treated with high-dose cyclophosphamide.

Key facts

Study ID

NCT00010413

Run by

Johns Hopkins University

People needed

35

Starts

1999-04-01

Last updated by the study team

2008-10-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Johns Hopkins University School of Medicine — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.